Significance and Status of smad4 Promoter Methylation in the Hans and Kazaks with Esophageal Squamous Cell Carcinoma in Xinjiang
-
摘要: 目的 研究新疆汉族与哈族(哈萨克族)食管鳞癌中smad4基因启动子区的甲基化水平及意义。方法 收集哈族食管癌组织37例和正常对照组织33例；汉族食管癌组织31例和正常对照组织33例。应用Mass ARRAY甲基化DNA定量分析技术对食管组织中smad4基因启动子区的甲基化水平行定量分析。结果 汉族与哈族食管癌组和对照组中smad4基因启动子区的平均甲基化率分别为3.4%和2.8%、 3.4%和2.5% ，差异均无统计学意义(P>0.05)。smad4基因启动子区CpG-15、CpG-27 在汉族食管癌中的平均甲基化率(4.7%、4.9%)明显高于对照组 (2.8%、3.5%)；CpG-1、CpG-16-19、CpG-27-28、CpG-31-33在哈族食管癌中的平均甲基化率(1.7%、4.5%、4.9%、6.8%)明显高于哈族对照组(0.7%、2.2%、3.0%、5.5%)，CpG-6在哈族食管癌和正常组织中的平均甲基化水平(1.9%、 1.1%)均明显高于汉族食管癌组(0.4%)，差异均有统计学意义(P<0.05)。结论 (1)smad4基因启动子区的高甲基化可能参与了食管癌的发生。(2)smad4基因启动子区CpG-15、CpG-27的高甲基化可能与汉族食管癌发生关系密切；而CpG-1、CpG-16-19、CpG-27-28、CpG-31-33的高甲基化可能是新疆哈族食管癌高发的原因；smad4 基因启动子区CpG-6的高甲基化可能导致哈族食管癌较汉族食管癌高发。Abstract: Objective To investigate the level and significance of smad4 promoter methylation in the Hans and the Kazaks with esophageal squamous cell carcinoma in Xinjiang. Methods We collected 37 cases of ESCC and 33 cases of local normal esophageal tissues of the Kazaks, and 31 cases of ESCC and 33 cases of local normal esophageal tissues of the Hans. Mass ARRAY methylation DNA quantitative analysis technology was used to detect the methylation status of smad4 gene promoter in ESCC. Results The average methylation rates of smad4 gene promoter CpG units were 3.4% in esophageal cancer in the Hans and 2.8% in relevant control group, 3.4% in esophageal cancer in the Kazaks and 2.5% in relevant control group, with no statistically significant difference (P>0.05). The average methylation rates of CpG-15 and CpG-27(4.7%, 4.9%) in smad4 gene in the Hans with ESCC were significantly higher than those in relevant control group (2.8%, 3.5%). The average methylation rates of CpG-1, CpG-16-19, CpG-27-28, CpG-31-33(1.7%, 4.5%, 4.9%, 6.8%) in smad4 gene in the Kazaks with ESCC were significantly higher than those in relevant control group (0.7%, 2.2%, 3.0%, 5.5%). The average methylation rates of CpG-6 in the Kazaks with ESCC and relevant control group (1.9%, 1.1%) were significantly higher than that in the Hans with ESCC(0.4%), with statistically significant difference (P<0.05). Conclusion Smad4 gene promoter hypermethylation may participate in the occurrence of ESCC. Hypermethylation of CpG-15 and CpG-27 in smad4 gene promoter may closely relate with the occurrence of ESCC in the Hans. Hypermethylation in CpG-1, CpG-16-19, CpG-27-28 and CpG-31-33 may closely relate with the occurrence of ESCC in the Kazaks. Hypermethylation in CpG-6 may result in higher incidence of ESCC in the Kazaks than that in the Hans.
-
Key words:
- Esophageal squamous cell carcinoma /
- Smad4 gene /
- Methylation /
- The Kazaks
-
-
[1] Li JY. Epidemiology of esophageal cancer in China[J]. Natl Cancer Inst Monogr,1982,62:113-20. [2] Zhang YM. The distribution of esophageal cancer in Xinjiang[J]. Xinjiang Yi Ke Da Xue Xue Bao, 1988,11(2):139-45.[张月明.新 疆食管癌的分布[J].新疆医科大学学报,1988,11(2):139-45.] [3] Zhang HX, Chen Y, Yin D, et al. Exploration of the risk factors of esophageal cancer in Xinjiang kazak nationality[J]. Xian Dai Yu Fang Yi Xue,2009,36(10):1804-6. [张慧霞,陈艳,尹东, 等. 新疆哈萨克族食管癌危险因素的探讨[J].现代预防医 学,2009,36(10):1804-6.] [4] Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1[J]. Science,1996, 27 1(5247):350-3. [5] Jain PK. Epigenetics: the role of methylation in the mechanism of action of tumor suppressor genes[J]. Ann N Y Acad Sci,2003,983:71-83. [6] Jones PA, Laird PW. Cancer epigenetics comes of age[J]. Nat Genet,1999,21(2):163-7. [7] Van De Voorde L, Speeckaert R, Van Gestel D, et al. DNA methylation-based biomarkers in serum of patients with breast cancer[J]. Mutat Res,2012,751(2):304-25. [8] Roossink F, de Jong S, Wisman GB, et al. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art[J]. Cell Oncol (Dordr), 20 12,35(4):231-41. [9] Chen J, Huang ZJ, Duan YQ, et al. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma[J]. Asian Pac J Cancer Prev,2012,13(10):5303-6. [10] Mao WM, Li P, Zheng QQ, et al. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer[J]. Arch Med Res,2011,42(3):182-8. [11] Zhang GY, Ma CX, Liu QL, et al. Detection of methylation of h MSH2 gene promoter region of esophageal cancer[J]. Zhonghua Zhong Liu Za Zhi,2005,27(9):541-3. [张功员,马春晓,刘秋亮,等. 食管癌组织中hMSH2基因启动子区甲基化检测[J].中华肿瘤杂 志, 2005,27(9):541-3.] [12] Hata A, Shi Y, Massagué J. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads[J]. Mol Med Today,1998,4(6):257-62. [13] Bierie B, Moses HL. TGF-beta and cancer[J]. Gytokine Growth Factor Rev,2006,17 (1-2):29-40. [14] Guo W, Dong ZM, Guo YL, et al. CpG island methylation of Smad4 gene in gastric cardia adenocarcinoma[J]. Ai Bian·Ji Bian·Tu Bian,2011,23(4):269-74.[郭炜,董稚明,郭艳丽,等. 贲 门腺癌中Smad4基因甲基化状态分析[J]. 癌变·畸变·突变， 20 11,23(4):269-74.] [15] Dong ZM, Guo W, Guo YL, et al. Methylation status of CpG island of Smad4 gene in esophageal squamous cell carcinoma[J]. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi,2010,17(6):597-603.[董稚明,郭炜,郭艳丽,等.食管鳞状细胞 癌中Smad4基因CpG岛甲基化状态分析[J].中国肿瘤生物治疗 杂志,2010,17(6):597-603.]
计量
- 文章访问数: 1156
- HTML全文浏览量: 336
- PDF下载量: 541
下载:
